Carcinoma, Non-Small-Cell Lung: all 6,641 studies
Page 5 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.
- The Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent PlatformsRecruitingNCT07310056Not applicable
- Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLCRecruitingNCT07309952Phase 2
- Nelmastobart in Combination With Docetaxel in Non Small Cell Lung CancerRecruitingNCT07306624Phase 2
- Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal MetastasesRecruitingNCT07304739Phase 2
- Evaluation of Lymph Node Analysis Using One Step Nucleic Acid Amplification (OSNA) in Patients With Lung Cancer Who Underwent Robotic Lung Resection, Comparison With Traditional MethodsEnrolling by invitationNCT07301983
- A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid TumorsRecruitingNCT07300150Phase 1
- Firmonertinib 160 mg in Patients With EGFR-Mutant Advanced NSCLC Demonstrating SD After 8 Week Induction With Firmonertinib 80 mgNot yet recruitingNCT07298148Phase 2
- Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLCNot yet recruitingNCT07294261Phase 2
- A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After TreatmentRecruitingNCT07293247Phase 2
- Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic AlterationsRecruitingNCT07291037Phase 3
- Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung CancerRecruitingNCT07288632
- Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung CancerRecruitingNCT07288177Phase 2
- Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP TrialRecruitingNCT07288034Phase 2
- A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsRecruitingNCT07287995Phase 1/2
- Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal DataNot yet recruitingNCT07287904
- Stereotactic Body Radiotherapy With Sequential Iparomlimab and Tuvonralimab (QL1706) + Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Non-small-cell Lung Cancer in China (LUNG-Nanjing01): a Single-arm, Single-centre, Phase 2 TrialNot yet recruitingNCT07286942Phase 2
- Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung CancerEnrolling by invitationNCT07285434Early Phase 1
- A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung CancerNot yet recruitingNCT07285148Phase 1/2
- First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid TumorsRecruitingNCT07284186Phase 1
- A Phase II Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics/Pharmacodynamics of JSKN033 in Patients With Advanced Non-Small Cell Lung CancerNot yet recruitingNCT07283198Phase 2
- Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.RecruitingNCT07279935Phase 4
- TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%RecruitingNCT07279402
- Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung CancerRecruitingNCT07276789Phase 2
- Hyperprogression in PD-L1 ≥ 50% NSCLC: a Biomarker Guided Phase 2 TrialNot yet recruitingNCT07274384Phase 2
- A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.Not yet recruitingNCT07272642Phase 1
- A Phase 2 Randomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer.Not yet recruitingNCT07271602Phase 2
- A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLCRecruitingNCT07269782Phase 2
- Minimal Residual Disease in Solid MalignanciesNot yet recruitingNCT07268469Not applicable
- EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCERRecruitingNCT07267000Not applicable
- Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT07264647Phase 2
- Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid TumorsRecruitingNCT07261631Phase 1
- Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System TherapyRecruitingNCT07257471
- Application of Methylation Markers in Early Detection and MRD Monitoring of Lung CancerRecruitingNCT07257458
- A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung CancerNot yet recruitingNCT07256509Phase 2
- Postoperative Pulmonary Function Assessment Based on Deep Learning StudyNot yet recruitingNCT07256457Not applicable
- Accuracy Between Transthoracal Needle Aspiration (TTNA) Techniques in Suspected Lung Cancer PatientsRecruitingNCT07255950Not applicable
- A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung CancerRecruitingNCT07253142Phase 2
- Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung CancerRecruitingNCT07250477Phase 2
- A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid TumorsRecruitingNCT07250386Phase 1
- DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung CancerRecruitingNCT07249372Phase 2
- Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)Not yet recruitingNCT07247786Phase 2
- Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry AnalysisNot yet recruitingNCT07246759
- Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)RecruitingNCT07243132
- Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC PatientsRecruitingNCT07242547Phase 2
- Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLCNot yet recruitingNCT07242274Phase 3
- Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLCRecruitingNCT07239661Not applicable
- Ensartinib After Chemoradiotherapy in Stage III ALK-Mutated NSCLCNot yet recruitingNCT07235306Phase 2
- Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain MetsNot yet recruitingNCT07234877Phase 2
- Is 3D Modeling From Non-contrast CT Accurate for Minimally Invasive Lung Segmentectomies ?Not yet recruitingNCT07234604
- A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid TumorsRecruitingNCT07232420Phase 1
- A Dose-escalation and Dose-expansion Phase I/Phase II Clinical Study of Dositinib Mesylate Tablets (90-1408) in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer With Positive EGFR MutationRecruitingNCT07231068Phase 1/2
- A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World SettingRecruitingNCT07230691
- A Phase II Study of SKB571 in Patients With Lung CancerRecruitingNCT07230405Phase 2
- A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung CancerRecruitingNCT07229729Phase 2
- A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsRecruitingNCT07229313Phase 1
- Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced CancersRecruitingNCT07227298Phase 1/2
- A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung CancerRecruitingNCT07227025Phase 1/2
- Promoting Immunotherapy Efficacy With Low-Dose Liver RTRecruitingNCT07225036Not applicable
- Impact of Circadian Rhythm on ImmunotherapyRecruitingNCT07224971Phase 2
- Patient Preference for Subcutaneous vs. Intravenous Immune TherapyRecruitingNCT07223424Phase 2
- A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid MalignanciesRecruitingNCT07223047Phase 1/2
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruitingNCT07222566Phase 3
- Retifanlimab and Ruxolitinib In Solid MalignanciesRecruitingNCT07219576Phase 1/2
- Engagement of Veterans With Lung CancerRecruitingNCT07219251Not applicable
- Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung CancerRecruitingNCT07218601Phase 2
- A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Enrolling by invitationNCT07218003Phase 1
- Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung CancerRecruitingNCT07216404Phase 2
- The Impact of Exercise on the Tumor Microenvironment in Patients With Lung CancerRecruitingNCT07216209Not applicable
- FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid TumorsRecruitingNCT07216105Phase 1
- Evaluating the Feasibility and Preliminary Effects of BE+Enrolling by invitationNCT07214441Not applicable
- High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /SegmentectomyRecruitingNCT07213375Phase 2/3
- A Study of YL201 and Ivonescimab (AK112) in Advanced Solid TumorsRecruitingNCT07208773Phase 1/2
- A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.RecruitingNCT07207395Phase 2
- A Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLCRecruitingNCT07206498Phase 1/2
- The IVO-LUNG StudyNot yet recruitingNCT07204548Phase 2
- DC/NK Cell TherapyRecruitingNCT07202611Phase 2
- A Study of YL202 in Patients With Advanced Solid TumorsRecruitingNCT07202364Phase 2
- A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer.Not yet recruitingNCT07200947Phase 2
- Study on the Mechanism of Acquired Resistance of EntrectinibRecruitingNCT07199959
- IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C MutationRecruitingNCT07198841Phase 2
- A Real-World Study of IBI351 for KRAS G12C+ NSCLC in ChinaNot yet recruitingNCT07198620
- Clinical Efficacy and Safety of Microwave Ablation Combined With Huaier Granules in Patients With Inoperable Stage IA Non-Small Cell Lung Cancer: A Prospective, Single-Center, Randomized Controlled Clinical TrialNot yet recruitingNCT07197853Phase 3
- Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD MutationsRecruitingNCT07195695Phase 3
- To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung CancerRecruitingNCT07195084Not applicable
- A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLCRecruitingNCT07193641Phase 2
- Sacituzumab Tirumotecan in Combination With Furmonertinib as Second-line Treatment for EGFR-mutant Advanced or Metastatic NSCLC After Failure of First-line Third-generation EGFR-TKI TherapyNot yet recruitingNCT07193160Phase 2
- Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.RecruitingNCT07192068Phase 2
- Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer PatientsRecruitingNCT07191171
- A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)RecruitingNCT07190248Phase 3
- Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized TrialNot yet recruitingNCT07190027Phase 1/2
- 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsRecruitingNCT07189871Phase 1/2
- Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUDRecruitingNCT07186699
- Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsRecruitingNCT07185997Phase 3
- Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung CancerNot yet recruitingNCT07185308Not applicable
- High-Dose Firmonertinib Plus Bevacizumab as Neoadjuvant Therapy for Resectable EGFRm Stage II-IIIB NSCLCNot yet recruitingNCT07182708Phase 2
- A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical SurgeryRecruitingNCT07182682Phase 3
- A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid TumorsRecruitingNCT07181473Phase 1
- Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLCNot yet recruitingNCT07177105Phase 2
- Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung CancerNot yet recruitingNCT07177092Phase 2
- Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer SubjectsRecruitingNCT07175220Phase 2